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AbSTRACT
ObJECTIvE To develop, implement and validate a 
framework and protocol directed to pharmacists regarding 
prescription of non-steroidal anti-inflammatory drugs 
(nsAIDs) and to propose a documentation system to be 
used when prescribing nsAIDs.
mEThOD A module highlighting the information 
on nsAID use and on pharmacists prescribing of nsAIDs 
was developed to be used as a tool for development of 
pharmacists’ knowledge to participate in the framework 
of pharmacist prescribing of nsAIDs. A protocol to be used 
when prescribing nsAIDs was developed. The developed 
protocol is concise and includes all relevant data.  Evaluation 
of the proposed module and protocol was carried out by an 
expert panel consisting of 14 professionals. The readability 
of the module was assessed.  A documentation system was 
set	up	using	Microsoft	Excel®	2007.
kEy fINDINgS A module named ‘supplementary 
Prescribing for Pharmacists’ was developed as a Power point 
Presentation	 using	Microsoft	 PowerPoint®	 2007.	 The	 final	
version of the module scored 55 in the flesch Reading Ease 
formula. The expert panel rated the overall presentation 
as very good. The module was considered a good tool of 
information for its intended purpose. Eleven healthcare 
professionals	 found	the	module	very	helpful	and	7	 found	
it very practical for its intended use. A protocol named: 
‘Protocol for Prescribing nsAIDs’ was developed. Twelve 
health care professionals found the protocol easy to use 
while 5 of the participants thought it was time consuming. 
CONCLuSION The module and protocol were very 
well accepted by the expert panel. Up till now there was 
a lack of protocols regarding nsAID use in malta and that 
some potential side effects pertaining to this class of drugs 
were not always taken into consideration while dispensing. 
This study is now proposing a module to establish a safe and 
standard practice for recommendation of use of nsAIDs.
kEy WORDS Pharmacists prescribing, nsAIDs, Protocol
INTRODuCTION
Pharmacists are healthcare professionals, who are experts in 
safe and effective medication use. Pharmacists prescribing 
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may lead to the full use of this expertise and thus benefiting 
from the full potential of the pharmacy profession. With the 
introduction of pharmacists prescribing rights, health care 
delivery would improve and time and cost to deliver patient 
care, would be reduced. 
There are two types of pharmacists prescribing, dependent 
and independent prescribing. In dependent prescribing, 
the physician and the pharmacist have equal responsibilities 
towards patient’s health. The physician diagnoses and 
makes treatment decisions whilst the pharmacist may 
select, monitor, modify or discontinue drug therapy.1,2 
In independent prescribing, the pharmacist prescriber takes 
responsibility for the clinical assessment of the patient by 
establishing a diagnosis, deciding the clinical management 
required and taking responsibility for appropriately 
prescribing where necessary.1,2
nsAIDs are known to cause gastrointestinal events which 
may cause complications such as gastro-intestinal ulceration 
and bleeding.3-9 They are also known to cause cardiovascular 
events such as increasing the risk of a myocardial infarction 
in susceptible patients.6,10-13 Other adverse effects of nsAIDs 
include renal impairment which leads to an increase in 
blood pressure if the patient is already hypertensive8,9,15 
and induction of bronchospasms especially if the patient 
already suffers from asthma.4,16,17	All these side effects and 
drug-drug interactions warrant pharmacists within an 
independent or dependent prescribing scenario to ensure 
patient safety.
The aims of the study were to develop and validate a 
framework and a protocol directed to pharmacists regarding 
prescription of nsAIDs and to propose a documentation 
system to be used when prescribing nsAIDs.
mEThODOLOgy
A module highlighting the information on nsAID use and 
pharmacists prescribing of nsAIDs was developed to be 
used as a tool for continuous development of pharmacists’ 
knowledge. This was done after thorough research 
regarding this class of drugs.
A protocol to be used as an aid for the safe prescribing of 
NSAIDs	was	then	drafted	using	Microsoft	Word®2007.
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After the module and protocol were ready, a documentation 
system was drafted with the help of a physician to ensure 
that all necessary data was included whilst keeping record 
of the prescribing activity.
health care professionals were asked to give feedback 
regarding the information on these tools using, a 
questionnaire which was developed and disseminated as a 
hard copy and an online version. The chi square test were 
used when 2 categorical variables needed to be analysed. 
RESuLTS
Out of the 20 health care professionals contacted, 14 answered 
the	questionnaire,	with	7	being	physicians	and/or	consultants	
and	 the	 other	 7	 being	pharmacists.	When	 comparing	 level	
of education with the profession it was observed that most 
pharmacists did not continue to post tertiary education as 
opposed to physicians (χ2	(1)	=	7.778,		p=0.005).
The module proposed was considered to be professional 
by 13 out of the 14 health care professionals in the expert 
panel. Its presentation and writing style were well accepted 
by	the	panel	which	rated	the	module	as	very	good	and/or	
excellent. The language, words and technical terms used 
were	all	considered	understandable	by	93%,	100%	and	86%	
of the expert panel respectively (χ2	 (2)	=	2.154,	 	p=0.341).	
Seventy	 one	 per	 cent	 (n=10)	 of	 the	 expert	 panel	 rated	
the way the module was written as very good. The flesch 
Reading ease score of the module was found to be 55. The 
module was found to be very helpful and very practical 
for	 its	 intended	 use	 by	 9	 physicians	 and	 8	 pharmacists	
(χ2	(1)	=	0.150,	p=0.699).
Although the proposed protocol was seen as very easy 
to	 use	 by	 93%	 (n=13)	 and	 the	 incorporated	 flow	 charts	
were rated as very clear and clear by 8 and 6 health 
care professionals respectively, it was found to be time 
consuming	by	43%	(n=6).	
Figure 1: Part of Proposed Protocol regarding nsAIDs
This module could be used in conjunction with 
a prescribing module to support pharmacists 
develop pharmacist prescribing for NSAIDs.
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DISCuSSION
When comparing the level of education with profession, 
it was observed that since the p-value obtained (0.005) is 
less the 0.05 level of significance, physicians tend to further 
their studies to a post tertiary level significantly more than 
pharmacists. 
for the proposed module, a flesch Reading ease score 
between 10 till 40 was aimed for, since it is targeted for 
professional people who have graduated with a University 
degree in pharmacy. The final version of the module 
scored 55 in the flesch Reading Ease score which is 
deemed satisfactory for this type of audience composed of 
graduated professionals.
There	 was	 no	 statistical	 difference	 (p=0.341)	 between	
how health care professionals rate the language, words 
and use of technical terms, which were found to be very 
understandable. The module was found to be very helpful 
and practical for its intended use. There was no statistically 
significant difference between helpfulness and practicality 
of	the	module	(p=0.699).
The proposed protocol was found to be time consuming 
by almost half of the expert panel, whilst almost all experts 
found the protocol to be easy to use and rated the steps as 
clear. One limitation of the study was that a small sample 
size was used to evaluate the module and protocol. It 
is recommended that the evaluation is implemented 
on a larger scale. The module included all information 
regarding safe use of nsAIDs but no information regarding 
prescribing skills. These skills are taught to physicians and 
are gained through experience. Information regarding such 
skills could be inserted in the module. 
CONCLuSION
The module regarding nsAIDs and the protocol regarding 
the use of these drugs suggested in this study are well 
accepted by both pharmacists and physicians. This module 
could be used in conjunction with a prescribing module to 
support pharmacists develop pharmacist prescribing for 
nsAIDs.
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